FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr.

(MedPage Today) -- An FDA advisory committee voted Thursday to remove compounding restrictions on two peptides--BPC-157 and KPV--despite little evidence the products are safe or effective for medical use.
BPC-157, touted by wellness influencers...